The improved Jellyfish Valve: durability enhancement with sufficient blood compatibility.

The Jellyfish Valve is one of the most promising polymer valves for artificial hearts. The present problems to be solved are 1) how to prevent a membrane fracture and 2) how to eliminate a calcification, because both of these problems were observed in experiments with goats after 312 days and 414 days of pumping. Finite element analysis demonstrated that mechanical tensile strain induced in the membrane at valve closure was clearly consistent with the fracture location as well as calcification area in in vivo experiments. Based on this finding, a new valve seat with an additional concentric ring 14 mm in diameter and 0.5 mm in width was finally developed. The maximum strain was dramatically reduced to 52% by the design improvement. Moreover, accelerated fatigue tests demonstrated that the improved valve was 10 times more durable as compared with the original valve, which was equivalent to an in vivo duration of 8.3 years. In animal experiments, including 31 days and 46 days use in a total artificial heart (TAH), no thrombus was found despite the lack of anticoagulant or antiplatelet therapies. These results indicate that the improved Jellyfish Valve might be one of the most durable polymer valves, able to perform in artificial hearts for a long period of time. ASAIO Journal 2002; 48:532-537.

[1]  T. Fujimoto,et al.  Design Improvement of the Jellyfish Valve for Long-term Use in Artificial Hearts , 2001, The International journal of artificial organs.

[2]  A. el-Banayosy,et al.  Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation. , 2000, Artificial organs.

[3]  L. Goubergrits,et al.  Novel cardiac assist valve with a purge flow in the valve sinus. , 1998, ASAIO journal.

[4]  K. Mabuchi,et al.  Physiological control of a total artificial heart: conductance- and arterial pressure-based control. , 1998, Journal of applied physiology.

[5]  J. Vašků,et al.  Electron microscopic study of driving diaphragms in long-term survival with a total artificial heart. , 1995, Artificial organs.

[6]  R L Kormos,et al.  Evaluation of Bioprosthetic Valve‐Associated Thrombus in Ventricular Assist Device Patients , 1993, Circulation.

[7]  T Chinzei,et al.  The second and third model of the flow transformed pulsatile total artificial heart. , 1992, ASAIO journal.

[8]  T Chinzei,et al.  Blood compatibility of the jellyfish valve without anticoagulant. , 1991, ASAIO transactions.

[9]  T Chinzei,et al.  In vitro and in vivo evaluation of a jellyfish valve for practical use. , 1989, ASAIO transactions.

[10]  K Atsumi,et al.  A newly designed jellyfish valve for an artificial heart blood pump. , 1988, ASAIO transactions.

[11]  H Reul,et al.  Comparative Evaluation of Disk- and Tri Leaflet Valves in Left-Ventricular Assist Devices (LVAD) , 1988, The International journal of artificial organs.

[12]  G. Rosenberg,et al.  Calcification inside artificial hearts: inhibition by warfarin-sodium. , 1980, Science.

[13]  I. Saito,et al.  Forty six days survival with the smallest implantable total artificial heart (THA), undulation pump TAH(UPTAH) , 2000 .

[14]  H. Harasaki,et al.  Calcification in blood pumps. , 1979, Transactions - American Society for Artificial Internal Organs.

[15]  K. Nolph,et al.  Factors affecting the ultrafiltration rate from standard dialysis coils. , 1970, Transactions - American Society for Artificial Internal Organs.